Back to search

Czechia· CZ-0131391

TERLIPRESIN ACETÁT EVER PHARMA

A terlipressin product containing terlipressin acetate, registered in Czechia by EVER-Valinject GmbH, Unterach am Attersee. The same ATC class is registered in 15 of our 19 countries.

ATC H01BA04

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedTERLIPRESIN ACETÁT EVER PHARMAATCH01BA04REGISTER NO.CZ-0131391PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Terlipressin is registered in 15 of 19 countries.

Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 9 of them publish a price we can compare per daily dose

Terlipressin · ATC H01BA04

15 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
TERLIPRESSIN ACETATE
Manufacturer
EVER-Valinject GmbH, Unterach am Attersee
Country
Czechia (CZ)
ATC code
H01BA04
ATC class
Terlipressin
Defined daily dose
12 mg, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0131391
    5X5ML
    CZK 4262.72

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terlipressin in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terlipressin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Glycylpressin
  • Belgium · Glypressin
  • Bulgaria · Реместип
  • Germany · Glycylpressin, Terlipressin Aftpharm
  • Denmark · Glypressin, Terlipressinacetat Sun
  • Estonia · Glypressin
  • Spain · Glypressin, Terlipresina Altan
  • Finland · Glypressin, Terlipressin Sun
  • France · Glypressine, Terlipressine Altan
  • United Kingdom (Northern Ireland) · Glypressin, Terlipressin Acetate Aft
  • Greece · Glypressin
  • Croatia · Glypressin
  • Ireland · Glypressin
  • Iceland · Glypressin
  • Italy · Terlipressina Sun
  • Lithuania · Glypressin
  • Luxembourg · Glypressin
  • Latvia · Glypressin
  • Netherlands · Glypressin, Terlipressine Sun
  • Norway · Glypressin
  • Poland · Glypressin, Terlipressin Acetate Altan
  • Portugal · Terlipressina Altan
  • Romania · Glypressin
  • Sweden · Glypressin, Terlipressin Sun
  • Slovenia · Glypressin
  • Slovakia · Glypressin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2fa0a119-67d9-4ca5-be5f-c57296855bc3
GET /v1/drugs/2fa0a119-67d9-4ca5-be5f-c57296855bc3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SOL",
  "source": "sukl",
  "strength": "0,2MG/ML",
  "pack_size": "5X5ML",
  "substance": "TERLIPRESSIN ACETATE",
  "cz_kod_sukl": "0131391",
  "product_type": "CH",
  "substance_codes": "17372",
  "registration_state": "R",
  "registration_number": "84/720/15-C"
}

See everything about terlipressin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.